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ABSTRACT
Introduction South Asians are at high risk of type 2 diabetes 
(T2D). We assessed whether intensive family- based lifestyle 
intervention leads to significant weight loss, improved 
glycaemia and blood pressure in adults at elevated risk for T2D.
Methods This cluster randomised controlled trial (iHealth- 
T2D) was conducted at 120 locations across India, Pakistan, 
Sri Lanka and the UK. We included 3684 South Asian men 
and women, aged 40–70 years, without T2D but with raised 
haemoglobin A1c (HbA1c) and/or waist circumference. 
Participants were randomly allocated either to the family- based 
lifestyle intervention or control group by location clusters. 
Participants in the intervention received 9 visits and 13 
telephone contacts by community health workers over 1- year 
period, and the control group received usual care. Reductions in 
weight (aim >7% reduction), waist circumference (aim ≥5 cm 
reduction), blood pressure and HbA1C at 12 months of follow- 
up were assessed. Our linear mixed- effects regression analysis 
was based on intention- to- treat principle and adjusted for age, 
sex and baseline values.
Results There were 1846 participants in the control and 1838 
in the intervention group. Between baseline and 12 months, 
mean weight of participants in the intervention group reduced 
by 1.8 kg compared with 0.4 kg in the control group (adjusted 
mean difference −1.10 kg (95% CI −1.70 to −1.06), p<0.001). 
The adjusted mean difference for waist circumference was 
−1.9 cm (95% CI −2.5; to 1.3), p<0.001). No overall difference 
was observed for blood pressure or HbA1c. People who 
attended multiple intervention sessions had a dose- dependent 
effect on waist circumference, blood pressure and HbA1c, but 
not on weight.
Conclusion An intensive family- based lifestyle intervention 
adopting low- resource strategies led to effective reduction 
in weight and waist circumference at 12 months, which has 
potential long- term benefits for preventing T2D. A higher 
number of attended sessions increased the effect on waist 
circumference, blood pressure and HbA1c.
Trial registration number EudraCT: 2016- 001350- 18;  
ClinicalTrials. gov: NCT02949739.
Key questions
What is already known?
 ► South Asians are at elevated risk for type 2 diabetes 
(T2D)—diet and physical activity are key modifiable 
risk factors for T2D and are, therefore, extensively 
used in lifestyle interventions and guidelines that 
aim to prevent or delay the onset of T2D.
 ► Although lifestyle interventions are effective for pre-
vention of T2D in South Asians, the approaches used 
to date are costly and labour intensive.
What are the new findings?
 ► We show that a lifestyle modification delivered by 
community health workers to South Asians with 
raised haemoglobin A1c or waist circumference is 
effective at reducing both weight and waist circum-
ference at 1 year.
 ► The improvement in weight and waist circumference 
is generalisable to different cultural groups and geo-
graphic settings.
 ► Our approach is developed to be scalable and sus-
tainable in both low–middle (income) and high- 
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INTRODUCTION
Type 2 diabetes (T2D) risk is exceptionally high among 
South Asians, who represent a quarter of the world popu-
lation, both in the country of origin and after migra-
tion.1 2 Diet and physical activity are key modifiable risk 
factors for T2D and are, therefore, extensively used in 
lifestyle interventions and guidelines that aim to prevent 
or delay the onset of T2D.3–5 Recent evidence from a 
meta- analysis with a total of 1816 participants from six 
randomised controlled trials (RCTs) (four from Europe 
and two from India) showed that these types of inter-
ventions can be effective to prevent T2D among South 
Asians as well.6
Studies conducted to date have provided some support 
for the provision of lifestyle intervention for the preven-
tion of T2D among South Asians, however, with signifi-
cant limitations. First, only few studies were completed 
in South Asian countries, with no studies reported from 
Pakistan. Moreover, the completed studies conducted in 
India7 8 and Sri Lanka9 10 are limited to local settings and 
small sample sizes. Second, the evidence- based approach 
established by studies to prevent T2D among South 
Asians lack scalability and sustainability for T2D preven-
tion, especially in low–middle- income settings. Previous 
lifestyle interventions to prevent T2D were designed 
in a way that are labour- intensive and costly, typically 
including one- to- one sessions with dedicated dieticians 
and the use of oral glucose tolerance tests for screening. 
To address these important limitations, we designed the 
iHealth- T2D trial to improve the scalability and sustain-
ability of lifestyle interventions in both low–middle- 
income and high- income settings.
The iHealth- T2D trial is a family- based lifestyle inter-
vention encompassing nine visits and 13 telephone calls 
delivered by community health workers. The iHealth- T2D 
study aims to (1) identify participants as being at risk for 
T2D based on parameters, which include low- resource 
strategies such as measuring waist circumference to iden-
tify people at risk and (2) improving cost- effectiveness and 
scalability through use of community health workers and 
an intensive family- based lifestyle intervention. Further-
more, we aimed to evaluate the effectiveness of the inter-
vention in different cultural settings in India, Pakistan, 
Sri Lanka and the UK, to improve generalisability of the 
research findings. Here, we first evaluate weight, waist 
circumference, blood pressure and haemoglobin A1c 
(HbA1c) in the intervention compared with the control 
arm between baseline and 12 months. In addition, treat-
ment compliance and behavioural changes are evaluated 
in the intervention arm. Second, we evaluate the effec-
tiveness of low- resource strategies used (raised HbA1c 
and/or waist circumference) to identify South Asians 
at risk for T2D subgroup analyses among participants 
included in the study.
METHODS
Study design and participants
iHealth- T2D is a cluster- RCT among 3684 South Asians 
at high risk of T2D at 120 locations across India, Paki-
stan, Sri Lanka and the UK. This is in accordance with 
power calculations in the study proposal for the primary 
end point, and these power calculations have been taken 
into account in the Statistical Analysis Plan (SAP).11 
The primary end point is new- onset T2D at 3 years. 
iHealth- T2D was designed to build on previous work, 
address key limitations in knowledge and explore more 
scalable approaches to delivery of lifestyle intervention 
among South Asians. The key innovations making the 
intervention more scalable compared with previous work, 
which include identification of South Asians at increased 
risk of T2D based on waist circumference and HbA1c 
(HbA1c was recently used to identify participant popula-
tions for the first time in the Norfolk Diabetes Prevention 
Study),12 and use of community health workers. A full 
description of the study design is available in Kasturiratne 
et al.13 In brief, a total of 120 sites from a range of socio-
economic settings and comprising both rural and urban 
were identified, with 30 sites in each of the four partici-
pating countries (India, Pakistan, Sri Lanka and the UK) 
were included. At each field- work location, we aimed to 
recruit 15 male and 15 female South Asians aged between 
40 and 70 years, at high risk, but free from T2D. Partici-
pants were identified at high risk of developing diabetes 
through screening. The recruitment to the study in 
India, Sri Lanka and Pakistan comprised inviting individ-
uals living in the community at study sites. Information 
on the project was distributed, and people were invited 
for screening through trusted sources of health informa-
tion including health centres, physicians and healthcare 
providers, grassroot- level non- physician health workers, 
accredited social health activists and volunteer groups. 
People were encouraged to discuss the project with neigh-
bours and friends to help widen engagement. In the UK, 
participants were exclusively approached by mail, from 
the practice lists of collaborating general practitioners. 
A secondary strategy in the UK took advantage of a data-
base comprising the results of cardiovascular health 
assessments with screening strategies identical to those 
of the iHealth- T2D study. This approach enabled identi-
fication of South Asians meeting the study entry criteria 
based on HbA1c or waist circumference, who were then 
invited directly to a study enrolment visit using a single 
Key questions
What do the new findings imply?
 ► Low- resource strategies such as measuring waist circumference 
to identify people as being at risk of T2D and the use of community 
health workers may be used to lower weight and waist circumfer-
ence among South Asians in both low–middle- income and high- 
income settings.
 ► Both weight and waist circumference are on the causal path to T2D; 
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letter of invitation. Screening participants were enrolled 
into the full trial if they fulfilled the criteria for high risk 
of T2D based on HbA1c ≥6.0% and/or waist circumfer-
ence ≥95 cm in Sri Lanka, or ≥100 cm in India, Pakistan 
and the UK. Exclusion criteria were known type 1 or T2D, 
fasting glucose levels ≥7.0 mmol/L, HbA1c levels ≥6.5%, 
body mass index (BMI) <22 kg/m2, pregnant or planning 
pregnancy, unstable residence or planning to relocate 
and serious illness (eg, cancer). The first participant was 
enrolled on 15 June 2016 and the last participant on 5 
March 2019. The last scheduled 1- year follow- up date 
was, thus, 4 March 2020.
The primary aim of the lifestyle intervention sessions 
was the prevention of T2D, through >7% wt loss 
and ≥5 cm reduction in waist circumference. Details on 
the lifestyle intervention are described in Kasturiratne 
et al13 and are also available on the study website ( www. 
ihealth- t2d. org). In brief, participants in the intervention 
arm received family- based lifestyle modification (LSM) 
including all the core Diabetes Prevention Programme 
design elements.5 The lifestyle intervention was deliv-
ered by a community health worker and consisted of 22 
contact sessions over a period of 12 months: nine clinic 
visits (four as one- to- one sessions, and five as group 
sessions), supplemented by 13 telephone contacts. Indi-
viduals were counselled on LSM, focusing on improved 
diet and increased physical activity. Recommendations to 
improve diet included attention to appropriate portion 
size, identifying cooking substitutions to reduce fat, 
increasing fruit and vegetable consumption, decreasing 
sugar intake and reducing alcohol consumption where 
appropriate. Suggestions to increase physical activity 
included finding enjoyable activities to pursue regularly 
and to incorporate physical activity into daily routines. 
The target was to achieve 150 min of moderate phys-
ical activity every week. Cultural adaptation was guided 
by in- country experts in nutrition, dietetics and public 
health. Comments were sought from potential partici-
pants, community health workers and other healthcare 
providers on draft materials before finalisation. Partic-
ipants in the control arm received a single diabetes 
prevention education session lasting 30–60 min deliv-
ered by a community health worker, and written material 
was distributed additionally.
The effectiveness of the iHealth- T2D trial is evaluated 
after two time points: at 1 and after 3 years of follow- up. 
Here we report on outcomes after 1 year follow- up. The 
final outcome (incident T2D) is evaluated after 3 years 
of follow- up, which will include an evaluation of cost- 
effectiveness. In this current study, we aimed to assess 
whether the intensive family- based lifestyle intervention 
programme leads to significant weight loss (weight, 
waist circumference), improved glycaemia (HbA1c) 
and blood pressure (systolic and diastolic) in adults at 
elevated risk for T2D between baseline and 12 months. 
Treatment compliance and behavioural changes are 
assessed.
Randomisation and masking
Neither participants nor community health workers 
could be blinded to the treatment arm as the type of care 
given is clearly visible. They were, however, kept masked 
to outcome measurements and trial results. Data were 
obtained by research nurses who were blinded to trial 
arms to reduce the risk of assessment bias. The field- work 
sites were cluster randomised to either family- based LSM 
or usual care (1:1 allocation) stratified by country and 
recruiting centre (two centres in Sri Lanka, five centres 
in India, two centres in Pakistan). Randomisation was 
done by the ICL team independent of the local investi-
gators. Participants were enrolled by the study research 
team and assigned to either the intervention or control 
arm based on their cluster. The cluster randomisa-
tion reduces the risk of resentful demoralisation and 
Hawthorne effect (contamination) during unblended 
interventions.14 15 Cluster randomisation was carried out 
before recruitment.
Measurements
Ethnicity was self- reported by the participants. Educa-
tional status, based on highest reported education, was 
used as proxy for socioeconomic status. Weight was meas-
ured in light clothing using portable digital scale accu-
rate to 0.1 kg and height using a portable stadiometer. 
BMI was determined by dividing measured weight (kg) 
by height squared (m2). Waist circumference was meas-
ured over bare skin at the midpoint between the lower 
margin of the last palpable rib and the top of the iliac 
crest. Waist measurements were taken three times and 
the average was calculated. Systolic blood pressure (SBP) 
and diastolic blood pressure (DBP) (mm Hg) were meas-
ured in the seated position using a digital device (Omron 
705, Omron Corporation, Kyoto, Japan). Three measure-
ments were obtained from each participant, 1 min apart, 
and after a rest period. HbA1c (%) was determined in 
fasting (overnight) venous blood samples. HbA1c was 
measured using Biorad D10 or Variant II turbo assays. 
Assays were performed in local laboratories that partici-
pate in external quality control and meet the standards of 
the International Federation of Clinical Chemists. Treat-
ment compliance was determined from the number of 
sessions attended by the participants in the intervention 
arm. Behavioural changes include assessment of known 
behavioural variables associated with T2D risk: alcohol 
consumption, smoking status and physical activity 
(online supplemental material 1. Alcohol consumption 
and smoking status were derived from the self- reported 
questionnaire. Moderate to vigorous- intensity physical 
activity (metabolic equivalents (MET)/week) and seden-
tary time (min/week) were determined for typical weeks 
with the Global Physical Activity Questionnaire.16
Statistical analyses
The statistical analyses followed the prespecified SAP.11 
Statistical analyses were performed by an investigator 
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for the intervention, on a clean anonymised data set 
(prepared by JC and AK). Analyses were based on the 
intention- to- treat principle, with data from all partici-
pants enrolled in the study,17 except for participants who 
withdrew their consent (n=8). Data of participants who 
attended at least one post- baseline session were analysed 
according to their initially assigned study arm, regard-
less of their adherence. Data completeness for baseline 
variables was almost 100% and approximately 89% at 12 
months follow- up, mainly due to loss to follow- up. We 
considered data to be missing at random based on the 
pattern of missing data. Therefore, multiple imputation 
was used to impute missing data. Variables selected as 
predictors for the imputation model contained known 
predictors of T2D. These include covariates included in 
the main analysis model (sex, age, country and site) and 
the auxiliary (baseline) variables (socioeconomic status, 
smoking status, alcohol consumption, physical activity, 
waist circumference and HbA1c). Missing values were 
imputed separately by allocated randomisation group.18 
The study was well powered to detect changes in study 
outcomes after 1- year follow- up. Assuming an intraclass 
correlation coefficient of 0.01, a two- sided p value of 0.05, 
a power of 0.80 and a 0%–20% dropout rate, the detect-
able differences are 0.80–0.88 kg in weight, 1.23–1.34 cm 
in waist circumference, 1.71–1.87 mm Hg in SBP, 0.92–
1.00 mm Hg in DBP and 0.05%–0.06% HbA1c.
The response rate is determined by dividing the 
number of people participating in the study by the 
number of people invited to the study. Baseline charac-
teristics of both study arms are presented in table 1 by sex 
and country. The baseline characteristics were not tested 
for statistical differences between study arms.19 Baseline 
characteristics are reported by arithmetic means and SD 
(normally distributed numerical data), medians and IQR 
ranges (non- normally distributed numerical data) or by 
percentages (categorical data). Normality of data distri-
butions was inspected visually by plotting histograms and 
additionally assessed by the Shapiro- Wilks test.
Differences in continuous outcomes between the two 
treatment arms were estimated with a multilevel linear 
mixed- effects regression model, which included the 
stratification variable site as a random effect and country 
as fixed effect to adjust for potential cluster differences. 
Analyses were adjusted for age, sex and baseline values. 
Including site in the model for weight resulted in high 
multicollinearity. We, therefore, considered site not to 
contribute to the model and omitted it in the model for 
weight. The estimates are presented with their associated 
95% CIs and p values for comparison between the treat-
ment groups. The multiplicative interaction of treat-
ment arm with sex, age, setting, socioeconomic status 
and baseline waist circumference and HbA1c levels 
were assessed. For the outcome weight, the multiplica-
tive interaction with weight instead of waist circumfer-
ence was assessed, to avoid multicollinearity. In addition, 
treatment compliance is reported as an explanatory 
variable in the treatment arm, according to the number 
of times a participant turned up for the LSM sessions. 
Behavioural changes were estimated by assessing change 
from baseline and 12 months in behavioural variables 
associated with T2D risk (alcohol consumption, smoking 
and physical activity).
Subgroup analyses of participants included in the study 
based on a high risk for T2D either according to waist 
circumference or HbA1c were performed. Sensitivity 
analyses were performed to identify potentially extreme 
centres, because extreme deviation of one site from other 
sites may have a large impact on the overall results. Addi-
tionally, complete case analyses were performed to assess 
the robustness of the results. Finally, any adverse events 
are reported.
Data are reported in line with the Consolidated Stan-
dards of Reporting Trials 2010 Statement.20 R V.3.6.3 (R 
Project for Statistical Computing) was used for the anal-
yses, with the mice package for multiple imputation.21 
Tests were two- sided and p values <0.05 were considered 
statistically significant. Analyses were not adjusted for 
multiple testing as hypotheses were pre- set.22
Ethics
Ethical approval was obtained from the Institutional 
Review Board in each participating country and at each 
research location before the start of the study. Informa-
tion sheets and consent forms were made available in the 
major South Asian languages. Multilingual translators 
were available as required. Each participant provided 
informed consent. People unwilling or unable to provide 
consent were excluded from the study. The research 
complied with relevant national and international regu-
lations and was carried out in line with the Declaration of 
Helsinki and the International Conference on Harmoni-
zation Guidelines.
Patient and public involvement
Local communities were involved in the design and adap-
tation process of the lifestyle intervention. Established 
trial protocols were tailored for use among South Asians 
to ensure they were acceptable, suited to the local envi-
ronment, sustainable and scalable. In South Asia, discus-
sions with community leaders and open meetings were 
held to identify suitable approaches for engaging local 
communities in the project. People were encouraged to 
discuss the project with neighbours and friends to help 
widen engagement. Family members of participants were 
strongly encouraged to join the programme, in particular, 
the children and the family cook(s). Family members 
were encouraged to make healthier choices, but without 
specific targets for weight and/or waist circumference 
unless they were also obese. Results of the study will be 
shared with study participants through the study website, 
and flyers and brochures will be circulated. Local media 
will be engaged to release press reports. Moreover, we will 
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Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation or writing of 
the report. The corresponding author had full access to 
all the data in the study and had final responsibility for 
the decision to submit for publication.
RESULTS
Participants were recruited between 15 June 2016 and 
05 March 2019. Figure 1 shows the trial profile of the 
iHealth- T2D study. The opportunistic, community- based 
recruitment strategies used in the South Asian subconti-
nent did not enable calculation of response rates. In the 
UK, the response rate to postal invitation was 22% (3 132 
people attending in response to 14 564 letters). Overall, 
there were 23 543 people who attended an iHealth- T2D 
screening visit. In addition, a database with 9699 South 
Asians aged between 40 and 70 years comprising the 
results of recent cardiovascular health assessments was 
used to screen participants in the UK. Of 33 242 people 
who were screened, 10 930 were invited for an assessment 
of eligibility, where 4263 people met the inclusion criteria 
and 3684 entered the trial as participants. The partici-
pants were randomised to clusters by 120 sites. A total 
of 1838 participants were assigned to the intervention 
and 1846 to the control arm, of whom 1636 participants 
(89%) in the intervention and 1623 (88%) in the control 
arm attended the 1- year follow- up examination.
Baseline characteristics of the studied population
Table 1 shows the baseline characteristics of women and 
men by trial arm and country. At baseline, the interven-
tion and control group were comparable in terms of 
metabolic and lifestyle- related characteristics (online 
supplemental table 1. Characteristics, however, varied by 
country and sex; 49.2% of the participants were woman 
and the mean enrolment age of participants was 52.8 (SD 
8.2) years. Many UK participants did not fill out their 
education and many Pakistani participants only attended 
primary school. BMI ranged from 27.5 kg/m2 among Sri 
Lankan men to 32.75 kg/m2 among Pakistani women. 
The majority of the participants were non- smokers. The 
majority of Pakistani men and women did not consume 
any alcohol, while a quarter of the men in India and half 
of the men in Sri Lanka and the UK reported alcohol 
consumption. Median moderate to vigorous- intensity 
physical activity ranged from zero MET/week among 
Indian participants to 1470 MET/week among Sri 
Lankan men.
Study outcomes after 1 year of follow-up
The weight (7%) target was reached by 13.6% of the 
participants in the intervention and 6.5% in the control 
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group, while the waist circumference target (≥5 cm) was 
met by 30.8 versus 19.4%. Table 2 shows that participants 
in the intervention group lost more weight and waist 
circumference than in the control group after 1 year of 
follow- up. The adjusted mean differences for weight and 
waist circumference in the intervention group compared 
with the control group were –1.1 kg (95% CI −1.7 to −0.6; 
p value <0.001) and −1.9 cm (95% CI −2.5 to −1.3; p value 
<0.001), respectively. In contrast, no statistically signifi-
cant differences between the two treatment arms were 
observed for systolic or DBP or for HbA1c.
We observed little evidence for multiplicative interac-
tions between treatment arm and sex, age, setting (the 
four different countries), waist circumference or HbA1c 
levels with any of the outcomes (weight; waist circumfer-
ence; HbA1c; blood pressure; data not shown). However, 
for participants who lived in Pakistan and/or did not 
enjoy schooling (groups showed overlap and cannot 
be disentangled), we found a multiplicative interaction 
between treatment arm and both systolic and DBP (p 
value=0.04). Specifically, among participants who lived in 
Pakistan and/or did not enjoy schooling, blood pressure 
increased in both the intervention and the control group, 
but the increase was lower in the intervention than the 
control group. (SBP among participants living in Paki-
stan: intervention arm increased from 127.1 (SD 18.2) 
to 129.9 (SD 19.7) mm Hg, while control arm increased 
from 128.6 (SD 18.6) to 133.8 (SD 20.9) mm Hg.
Subgroup analyses for participants stratified by inclu-
sion based on raised HbA1c and/or waist circumference 
are shown in table 3. Outcomes were similar in both 
inclusion groups for weight and waist circumference. A 
numerically larger effect of the intervention on blood 
pressure was observed for the participants included 
in the study based on elevated HbA1c levels compared 
with participants included based on waist circumference. 
Moreover, a statistically significant decrease in DBP was 
observed for the HbA1c inclusion group in contrast to 
the effect observed in the overall group (adjusted group 
difference HbA1c group −1.6 mm Hg (95% CI −2.8 to 
−0.4; p value=0.009)). However, the formal test for effect 
modification by HbA1c levels was not statistically signifi-
cant (p value=0.06).
LSM sessions were mostly completed as planned, the 
median number of sessions for the intervention group 
was 18 (IQR 6–22). 665 participants (36%) completed all 
22, while 1200 (65%) completed at least half of the inter-
vention sessions. For participants who attended every 
session a 3.37 cm decrease in waist circumference and 
1.86 kg reduction in weight can be observed (figure 2). 
This decrease in weight and waist circumference was 
similar for participants who attended less sessions. Blood 
pressure and HbA1c, however, depended on the number 
of sessions attended. A statistically significant difference 
was observed for participants attending 1–5 sessions 
(SBP, DBP and HbA1c), participants attending 5–10 
sessions (DBP only) and participants attending 11–15 
sessions (HbA1c only) compared with those attending 
all 22 sessions. For instance, HbA1c levels increased by 
0.05 % among participants attending all 22 sessions, while 
it increased by 0.16 % among participants attending 1–5 
sessions (p value=0.002).
No adverse events from the intervention were found.
Sensitivity analyses did not identify extreme centres to 
influence the findings. Complete case analyses showed 
similar results as the multiple imputation approach.
DISCUSSION
Our study suggests that a family- based LSM consisting of 
22 sessions and delivered by community health workers 
is effective to decrease weight and waist circumference 
among South Asians at high risk for T2D, in comparison 
with usual care. This effect was observed both for partic-
ipants identified at high risk for T2D based on raised 
HbA1c and waist circumference, and in South Asians 
living in low–middle- income country and high- income 
country settings. No statistically significant effect of the 
Table 2 Weight, waist circumference, blood pressure and HbA1c between baseline and 12 months
Baseline Follow- up Adjusted difference (95% CI) P value
Weight (kg) Intervention 80.3 (13.7) 78.5 (13.8) −1.1 (−1.7 to −0.6) <0.001
Control 79.2 (13.5) 78.8 (14.0)
Waist circumference (cm) Intervention 103.9 (9.3) 101.0 (10.0) −1.9 (−2.5 to −1.3) <0.001
Control 103.9 (9.4) 103.0 (9.9)
SBP (mm Hg) Intervention 130.7 (16.9) 130.5 (17.0) −0.8 (−2.2 to 0.6) 0.248
Control 131.8 (17.1) 132.2 (17.5)
DBP (mm Hg) Intervention 81.0 (10.2) 80.5 (10.2) −0.7 (−1.5 to 0.2) 0.130
Control 81.6 (10.4) 82.0 (10.4)
HbA1c (%) Intervention 5.8 (0.4) 5.8 (0.6) 0.0 (−0.1 to 0.0) 0.705
Control 5.7 (0.4) 5.8 (0.5)
N=1838 for intervention group; N=1846 for control group. Data are presented as mean and SD. Adjusted group differences are adjusted for 
stratification variables at randomisation (country and site) confounders (sex and age) and for corresponding baseline value.
















ealth: first published as 10.1136/bm






Muilwijk M, et al. BMJ Global Health 2021;6:e006479. doi:10.1136/bmjgh-2021-006479 9
BMJ Global Health
intervention was observed on blood pressure or HbA1c. 
However, DBP did decrease among participants identi-
fied at high risk for T2D based on the HbA1c inclusion 
criterion. In addition, the reduction in waist circumfer-
ence, blood pressure and HbA1c in the intervention arm 
was dependent on the number of LSM sessions attended.
Weight and waist circumference are important risk 
factors for T2D.23 24 Weight loss, especially in the abdom-
inal area, is, therefore, considered an important measure 
to counteract the development of T2D.25 Our study 
showed that weight and waist circumference decreased 
in the intervention compared with the control group. 
Importantly, the effect was dose dependent for waist 
circumference. Effect sizes were limited, but comparable 
or somewhat larger than that of other studies. Our study 
found reductions of 1.1 kg in weight and 1.9 cm in waist 
circumference, while a recent meta- analysis including a 
total of 1816 South Asian participants reported a reduc-
tion of 0.75 kg and 1.16 cm,6 respectively. According 
to this meta- analysis, modest adiposity changes even-
tually resulted in a 35% relative reduction in diabetes 
incidence.6
Our study adds to the already existing evidence 
that LSM can also be effective among South Asians, if 
approaches taken for identification of high- risk individ-
uals and delivery of the intervention are low- resource 
intensive. This makes the intervention especially sustain-
able and scalable for low–middle- income settings. Most 
other trials typically used resource- intensive strategies 
such as oral glucose tolerance tests for risk identification. 
Our study suggests that the approach of risk identification 
based on waist circumference and HbA1c are strategies 
that may work effectively. HbA1c has the advantage over 
other strategies such as oral glucose- tolerance tests of 
being a non- fasting assay, which is simpler and cheaper to 
administer.26 Waist circumference is an anthropometric 
and non- invasive measure, which is a simple, readily avail-
able clinical measure of adiposity and can be measured 
by subjects in the community once adviced.27 This makes 
waist circumference and HbA1c tools well suited for 
community- wide risk stratification and opportunistic 
screening. Delivery of health promotion for prevention 
of chronic disease has traditionally been the responsibility 
of physicians and allied health professionals. However, 
Table 3 Outcomes between baseline and 12 months by subgroups of participants enrolled into the trial if they had central 
obesity and/or elevated HbA1c levels
Baseline Follow- up Adjusted difference (95% CI) P value
Inclusion based on central obesity
  Weight (kg) Intervention 83.1 (12.8) 81.4 (13.0) −1.1 (−1.7 to −0.5) <0.0014
Control 81.8 (12.9) 81.4 (13.6)
  Waist circumference (cm) Intervention 106.6 (7.5) 103.1 (9.1) −1.8 (−2.4 to −1.3) <0.001
Control 106.6 (7.7) 105.1 (9.1)
  SBP (mm Hg) Intervention 131.0 (16.6) 130.6 (16.8) −0.9 (−2.3 to 0.6) 0.23
Control 132.4 (17.0) 132.5 (17.1)
  DBP (mm Hg) Intervention 81.3 (10.1) 80.9 (10.1) −0.6 (−1.5 to 0.3) 0.19
Control 82.2 (10.4) 82.4 (10.2)
  HbA1c (%) Intervention 5.8 (0.4) 5.8 (0.6) −0.02 (−0.07 to 0.02) 0.35
Control 5.7 (0.4) 5.8 (0.5)
Inclusion based on HbA1c
  Weight (kg) Intervention 76.2 (14.5) 74.5 (14.7) −1.5 (−2.3 to −0.6) <0.001
Control 75.4 (13.9) 75.2 (14.5)
  Waist circumference (cm) Intervention 100.4 (10.6) 98.3 (11.1) −2.1 (−3.0 to −1.2) <0.001
Control 100.6 (11.1) 100.5 (11.0)
  SBP (mm Hg) Intervention 130.3 (17.5) 132.4 (18.2) −1.5 (−3.6 to 0.5) 0.14
Control 131.4 (17.2) 130.1 (17.2)
  DBP (mm Hg) Intervention 80.5 (10.4) 79.7 (10.5) −1.6 (−2.8 to −0.4) 0.009
Control 80.6 (10.4) 81.6 (10.9)
  HbA1c (%) Intervention 6.2 (0.1) 6.2 (0.7) −0.01 (−0.08 to 0.06) 0.69
Control 6.2 (0.1) 6.2 (0.5)
Data are presented as mean and SD. Adjusted group differences are adjusted for stratification variables at randomisation (country and site), 
confounders (sex and age) and for corresponding baseline value.
















ealth: first published as 10.1136/bm






10 Muilwijk M, et al. BMJ Global Health 2021;6:e006479. doi:10.1136/bmjgh-2021-006479
BMJ Global Health
recent research supports the view that community health 
workers can make an effective contribution in prevention 
of T2D,28 and these can deliver LSM for prevention of 
T2D at lower cost, which, thus, provides a possible model 
for sustainable health promotion in low–middle- income 
settings. In our study, community health workers with a 
biological science background and recruited among the 
local community in which they worked, to ensure natural 
cultural awareness, were trained.
We did not observe an effect of the intervention 
on blood pressure or HbA1c in the intervention arm 
compared with the control arm. However, an effect was 
observed among participants included in the study based 
on their HbA1c levels, possibly since HbA1c is likely a 
better predictor of future T2D diagnosis than raised 
waist circumference. In addition, dose–response effects 
by number of attended LSM sessions were observed in 
the intervention arm. This may imply that the number 
of sessions is important to the effect of the study, or that 
participants attending more sessions were more moti-
vated to change their behaviour.
Alcohol consumption and smoking were not very prev-
alent in this population, and, therefore, we were not able 
to assess changes in these behaviours. The iHealth- T2D 
intervention showed an improvement in moderate and 
vigorous activity levels in both the intervention and control 
groups but was not able to increase physical activity in the 
intervention compared with the control group. Moderate 
to vigorous levels of physical activity were low, especially 
among participants from India, and may, thus, be a target 
among South Asians in order to prevent T2D. Future 
studies could also consider including strength exercise to 
improve T2D risk. Reduced muscular strength is a modi-
fiable risk factor for T2D and is recently added to guide-
lines to prevent T2D.29 Since muscle strength is relatively 
low among South Asian populations, this may be a target 
among these populations as well.30
Participants were recruited from 120 sites divided 
equally between India, Pakistan, Sri Lanka and the UK. 
The study, thus, included both non- migrant and migrant 
South Asians. On the South Asian subcontinent, recruit-
ment sites were based in a range of socioeconomic and 
geographic settings, to increase the generalisability of 
the findings (though participants in India were mainly 
reflective of the upper socioeconomic strata, reflecting 
the recruitment through private hospitals). In addition, 
Figure 2 Change in (A) weight, (B) waist circumference, (C) systolic blood pressure, (D) diastolic blood pressure and (E) 
HbA1c after 1 year of follow- up. N=665 for the reference group who attended all 22 sessions; N=438 for 1–5 sessions; 
N=200 for 6–10 sessions; N=144 for 11–15 sessions; N=391 for 16–21 sessions. Adjusted group differences are adjusted for 
stratification variables at randomisation (country and site), confounders (sex and age) and for corresponding baseline value. 
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equal numbers of men and women were included. None-
theless, if a lifestyle intervention is developed for other 
regions, elements may need to be adapted to the specific 
South Asian population targeted, since heterogeneity 
may exist in both genetic aetiology and in lifestyle factors.
Our study has certain limitations. First, we were not 
able to evaluate a change in dietary behaviours as they 
were only available for the intervention arm at baseline. 
This has limited us in the evaluation of change in explan-
atory variables underlying the effect of the intervention. 
Second, it was not possible to blind participants and 
community health workers to their treatment allocation, 
as both are actively involved in the intervention. Since the 
study was only partially blinded, there might be a risk of 
bias, for instance, during taking measurements. Finally, 
although our intervention study used low- resource strat-
egies to identify potential participants for the study, LSM 
is generally resource intensive. However, we sought to 
reduce costs through group, rather than individual inter-
vention, delivered by trained community health workers, 
rather than specialist professionals. We did not assess 
here whether the iHealth- T2D trial was cost- effective, 
however, this assessment will follow in future studies.
In conclusion, the iHealth- T2D trial is effective to 
reduce weight, BMI and waist circumference between 
baseline and 12 months. Since these are important modi-
fiable risk factors for T2D, the iHealth- T2D trial is likely 
to prevent or delay the onset of T2D in both indigenous 
and migrant South Asians at high risk of T2D. Finally, the 
iHealth- T2D trial shows that a family- based intensive LSM 
programme with a low availability of resources is likely 
to be effective in preventing T2D among high- risk South 
Asians in a wide range of settings.
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Supplementary material 1 
Behavioural changes 
No effect of the intervention compared to the control was observed on smoking status, alcohol 
consumption or METs of moderate to vigorous activity between baseline and 12 months of follow-up. 
Physical activity increased in both the intervention and the control group ((from 300 MET [IQR 190; 
1,440] to 500 MET [IQR 80; 1,040] and from 240 MET [IQR 125; 1,320] to 440 MET [IQR 80; 920] 
respectively; adjusted group difference -29 MET [95% CI -296; 239]). 
 
Supplementary table 1 
 Intervention group Control group 
Number of participants 1,838 1,846 
Age (Years), median (IQR) 52.4 (45.7-60.2) 52.6 (46.7-60.4) 
Setting, (%) n    
Urban 64.0% (1176)  62.5% (1154) 
Semi-urban 3.3% (60) 1.6% (30) 
Rural 32.8% (602) 35.9% (662) 
Schooling, (%) n    
Not reported 16.5% (303) 14.8% (274) 
No schooling 8.8% (161) 15.1% (278) 
Primary school 9.9% (182) 11.1% (204) 
Secondary school 25.9% (476) 21.6% (399) 
High school 17.5% (321) 17.8% (329) 
University degree 15.0% (275) 13.6% (251) 
Postgraduate 6.5% (120) 6.0% (111) 
Weight (kg), mean (SD) 80.3 (13.7) 79.2 (13.5) 
BMI (kg/m2), mean (SD) 30.3 (4.5) 30.2 (4.6) 
Waist circumference (cm), mean (SD) 104 (9.4) 104 (9.3) 
SBP (mm/hg), mean (SD) 131 (16.9) 132 (17.1) 
DBP (mm/hg), mean (SD) 81.0 (10.2) 81.6 (10.4) 
HbA1c (mmol/L), mean (SD) 5.8 (0.4) 5.8 (0.4) 
Smoking status % (n)   
Never 86.0% (1581) 86.2% (1592) 
Ex-smoker 8.6% (158) 7.7% (143) 
Current smoker 5.4% (99) 6.1% (112) 
Alcohol consumption last month % (n)   
No 81.9% (1506) 85.2% (1573) 
Yes 18.1% (332) 14.8% (274) 
Physical activity (MET/week), median (IQR) 300 (0-1440) 240 (0-1320) 
Sedentary (min/week), median (IQR) 460 (180-480) 360 (180-480) 
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